课题基金 / 基金详情

项目摘要

项目成果

John A Nyman的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由投保人提供):道德风险是指因投保而产生的额外医疗费用。传统理论认为道德风险是福利减少,但这没有考虑到由于收入从购买保险并保持健康的人转移到购买保险并患病的人身上而购买的额外医疗保健。对这种收入效应的认识表明,一部分是福利减少,另一部分是福利增加。如果保险公司向消费者支付了一张本票,金额等于保险公司根据标准保险单支付的他或她的医疗保健支出的部分,则可以通过保险消费者购买的额外医疗保健来估计福利增加的部分。这项研究没有进行昂贵的兰德型医疗保险试验,而是建议使用1996-2008年医疗支出小组调查来估计因保险而增加的额外医疗保健中福利增加的部分,并对(A)普通美国人,(B)那些分别具有15种优先健康状况中的9种的美国人,以及(C)所有15种优先健康状况加在一起。它将使用7个步骤的过程来(1)使用工具变量方法来估计医疗保健支出,以校正私人和公共健康保险的内生性,考虑到公共保险的可能选择,(2)对于每个未参保的人,根据步骤1中的收入系数估计需求的收入弹性,(3)对于私人参保的人,估计本应由保险公司支付的总支出的部分(不包括成本分摊),(4)对于每个未参保的人,使用步骤3的系数来估计保险公司支付的支出金额,如果他们已经投保,(5)对于每个未参保的人,如果他们投保了与步骤4相同的支出的或有索赔保险单,则使用步骤2中的收入系数来估计未参保医疗保健支出的变化,(6)对于每个未参保的人,使用步骤1中的系数估计道德风险支出,如果他们已经投保,以及(7)对于每个未参保的人,将个人从步骤5开始通过或有索赔合同投保的医疗保健支出的变化乘以未投保州的估计支出,以确定额外医疗保健支出的有效部分。然后,将这种具有或有索赔政策的有效支出与步骤6中估计的总体道德风险支出进行比较,以确定低效道德风险的数量。对于被保险人和整个样本,将重复类似的程序。这项研究首次估计了道德风险中有效的部分。这些信息将被用来推断美国医疗保健总支出中代表有效道德风险的比例,也将被用来评估对不同优先健康状况的参保人实施费用分担的适当性。
英文摘要
DESCRIPTION (provided by applicant): Moral hazard is the additional health care that is consumed because of insurance. Conventional theory regards moral hazard as being welfare decreasing, but this does not account for the additional health care that is purchased because of the transfer of income from those who purchase insurance and remain healthy, to those who purchase insurance and become ill. Recognition of this income effect suggests that a portion is welfare decreasing but another portion is welfare increasing. The welfare-increasing portion can be estimated by the additional health care that an insured consumer would have purchased if, instead of paying for any care, the insurer had paid him a cashier's check in an amount equal to the portion of his or her health care expenditures covered by the insurer under the standard insurance policy. Rather than conducting an expensive RAND-type of health insurance experiment, this study proposes to estimate the welfare-increasing portion of the additional health care due to insurance using the 1996-2008 Medical Expenditure Panel Survey, and to do so for (a) the general population of Americans, (b) those Americans with 9 of the 15 priority health conditions separately, and (c) all 15 priority health conditions combined. It will use a 7-step process to (1) estimate health care spending using an instrumental variables approach to correct for the endogeneity of private and public health insurance, taking into account the possible choice of public insurance, (2) for each uninsured, estimate the income elasticity of demand from the income coefficients in step 1, (3) for the privately insured, estimate the portion of total spending that would have been paid for by the insurer (excluding cost sharing), (4) for each uninsured, use the coefficients from step 3 to estimate the amount of spending paid for by the insurer if they had been insured, (5) for each uninsured, use the income coefficients from step 2 to estimate the change in uninsured health care spending if they were insured with a contingent claims insurance policy that paid off with the same spending as in step 4, (6) for each uninsured, use the coefficients from step 1 to estimate the moral hazard spending if they had been insured, and (7) for each uninsured, the change in health care spending had the individual been insured by a contingent claims contract from step 5 is multiplied by the estimated spending in the uninsured state to determine the efficient portion of the additional health care spending. This efficient spending with a contingent claims policy is then compared to estimated overall moral hazard spending from step 6 to determine the amount of inefficient moral hazard. An analogous procedure will be repeated for the insured and for the entire sample. This study represents the first to estimate the portion of moral hazard that is efficient. This information wil be used to make inferences about the proportion of the total health care spending in the U.S. that represents efficient moral hazard, and also will be used to evaluate appropriateness of imposing cost sharing on insured persons with the various priority health conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Decomposition of Moral Hazard
  • 批准号:
    8441384
  • 项目类别:
  • 资助金额:
    $17.03万
  • 财政年份:
    2012
  • 负责人:
    John A Nyman
  • 依托单位:
Estimating Efficient Moral Hazard: Spending Where Willingness-to-Pay Exceeds Cost
  • 批准号:
    8272028
  • 项目类别:
  • 资助金额:
    $8.59万
  • 财政年份:
    2012
  • 负责人:
    John A Nyman
  • 依托单位:
Decomposition of Moral Hazard
  • 批准号:
    8189501
  • 项目类别:
  • 资助金额:
    $17.21万
  • 财政年份:
    2012
  • 负责人:
    John A Nyman
  • 依托单位:
Nationally Representative Quality-of-Life Weights
  • 批准号:
    7088860
  • 项目类别:
  • 资助金额:
    $12.01万
  • 财政年份:
    2005
  • 负责人:
    John A Nyman
  • 依托单位:
海外基金